Gemcitabine Plus Nab-Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
Br. J. Cancer 2022 Jun 01;126(10)1394-1400, S Zaibet, V Hautefeuille, E Auclin, A Lièvre, D Tougeron, M Sarabi, M Gilabert, J Wasselin, J Edeline, P Artru, D Bechade, C Morin, A Ducoulombier, J Taieb, S PernotFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.